These final results, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 aid the strategy of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Issues. In reaction to https://joans405qps3.bligblogging.com/profile